7月7日Evaluating time to withdrawal of anti-Cancer drug indications that received FDA's accelerated approvalQJMHakariya H, Ozaki A, Mulinari S, Moriarty F, Tanimoto T2024/6/12https://pubmed.ncbi.nlm.nih.gov/38867701/
QJMHakariya H, Ozaki A, Mulinari S, Moriarty F, Tanimoto T2024/6/12https://pubmed.ncbi.nlm.nih.gov/38867701/
Comments